Ostro’s Post

View organization page for Ostro, graphic

4,442 followers

On its 10th year anniversary, Exact Sciences' Cologuard, a noninvasive, at-home alternative to colonoscopy, is a prime example of how consumerization can apply to diagnostics. Through convenience and accessibility, Cologuard has been: (1) used by 16 million patients (2) detected 525,000 cases of advanced precancerous lesions (3) identified 42,000 cases of Stage I cancer (4) saved the US healthcare system $22 billion Check out Chase Feiger, M.D.'s new Forbes article to read more about this impactful organization. ↓

View profile for Chase Feiger, M.D., graphic

Ostro

While the consumerization of healthcare has simplified access to care for lifestyle conditions like acne and hair loss, its impact on more serious conditions, such as cancer, has only recently begun to emerge. On its 10th year anniversary, Exact Sciences' Cologuard, a noninvasive, at-home alternative to colonoscopy, is a prime example of how consumerization can apply to diagnostics. Through convenience and accessibility, Cologuard has been: (1) used by 16 million patients (2) detected 525,000 cases of advanced precancerous lesions (3) identified 42,000 cases of Stage I cancer (4) saved the US healthcare system $22 billion It was a pleasure speaking with Kevin Conroy, Jake Orville, Jaime LaMontagne, Mark Fallai, on Exact Sciences' decade milestone. Check out my latest Forbes article to learn more! cc: Morry Smulevitz, Stephanie Spanos, Blair B.

A Consumerized Diagnostic: Looking Back And Ahead On A Decade Of Cologuard

A Consumerized Diagnostic: Looking Back And Ahead On A Decade Of Cologuard

social-www.forbes.com

To view or add a comment, sign in

Explore topics